ScholarGate
Assistent

Methoden vergelijken

Bekijk de geselecteerde methoden naast elkaar; rijen die verschillen zijn gemarkeerd.

Risico-gecorrigeerde Fase III Klinische Proef×Gekoppelde Gerandomiseerde Klinische Trial×
VakgebiedEpidemiologieEpidemiologie
FamilieProcess / pipelineProcess / pipeline
Jaar van ontstaan1980s–presentMid-20th century concept; methodological formalization circa 2000–2010
GrondleggerEvolving practice; foundational risk-adjustment principles established by Pocock (1983) and extended by numerous trialistsDeveloped formally in biostatistics literature; Greevy, Imai and colleagues advanced modern frameworks in the 2000s
TypeConfirmatory randomized trial with baseline risk stratification and covariate adjustmentExperimental clinical study design
Oorspronkelijke bronPocock, S. J. (1983). Clinical Trials: A Practical Approach. Wiley. ISBN: 978-0471901556Imai, K., King, G., & Nall, C. (2009). The essential role of pair matching in cluster-randomized experiments, with application to the Mexican universal health insurance evaluation. Statistical Science, 24(1), 29–53. DOI ↗
Aliassenrisk-stratified Phase III trial, covariate-adjusted Phase III RCT, risk-adjusted confirmatory trial, RA-Phase IIImatched RCT, matched-pair randomized trial, matched randomized controlled trial, covariate-matched RCT
Verwant66
SamenvattingA risk-adjusted Phase III clinical trial is a large-scale confirmatory randomized experiment that explicitly incorporates participants' baseline prognostic risk profile into both the randomization process and the primary statistical analysis. By stratifying patients on known risk factors before allocation and adjusting for those factors in the outcome model, the design achieves greater statistical precision, reduces confounding, and produces treatment effect estimates that are more clinically meaningful across patient subgroups.A matched randomized clinical trial pairs participants (or clusters) on key baseline characteristics before randomization, then allocates one member of each pair to treatment and the other to control. This design combines the causal validity of randomization with the covariate balance of matching, increasing statistical efficiency and reducing confounding from known prognostic variables without sacrificing the internal validity of a controlled experiment.
ScholarGateGegevensset
  1. v1
  2. 2 Bronnen
  3. PUBLISHED
  1. v1
  2. 2 Bronnen
  3. PUBLISHED

Naar zoeken Dia's downloaden

ScholarGateMethoden vergelijken: Risk-adjusted Phase III clinical trial · Matched Randomized Clinical Trial. Geraadpleegd op 2026-06-20 via https://scholargate.app/nl/compare